Advanced Enzyme Tech Intrinsic Value
ADVENZYMES Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹340.56 | ₹272.45 - ₹408.67 | +15.5% | EPS: ₹15.48, Sector P/E: 22x |
| Book Value Method | asset | ₹737.25 | ₹663.52 - ₹810.98 | +150.0% | Book Value/Share: ₹667.73, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹589.80 | ₹530.82 - ₹648.78 | +100.0% | Revenue/Share: ₹354.55, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹589.80 | ₹530.82 - ₹648.78 | +100.0% | EBITDA: ₹280.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹603.45 | ₹482.76 - ₹724.14 | +104.6% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹99.07 | ₹89.16 - ₹108.98 | -66.4% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹239.17 | ₹215.25 - ₹263.09 | -18.9% | Revenue Growth: 6.0%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹589.80 | ₹530.82 - ₹648.78 | +100.0% | ROE: 12.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹482.25 | ₹434.03 - ₹530.48 | +63.5% | EPS: ₹15.48, BVPS: ₹667.73 |
Want to compare with current market value? Check ADVENZYMES share price latest .
Valuation Comparison Chart
ADVENZYMES Intrinsic Value Analysis
What is the intrinsic value of ADVENZYMES?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Advanced Enzyme Tech (ADVENZYMES) is ₹589.80 (median value). With the current market price of ₹294.90, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹99.07 to ₹737.25, indicating ₹99.07 - ₹737.25.
Is ADVENZYMES undervalued or overvalued?
Based on our multi-method analysis, Advanced Enzyme Tech (ADVENZYMES) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.71 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 33.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.48x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Advanced Enzyme Tech
Additional stock information and data for ADVENZYMES
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹143 Cr | ₹98 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹141 Cr | ₹109 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹140 Cr | ₹-3 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹122 Cr | ₹122 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹163 Cr | ₹150 Cr | Positive Free Cash Flow | 8/10 |